Position in PFE
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$272,104
-$62,693 QoQ
Shares Held
11,300
-5.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2,201
of 2,821 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Canvas Wealth Advisors, LLC holds $4,522,294 across 7 Drug Manufacturers - General names. PFE ranks #5 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,493 | $1,790,749 | |
| 2 | JNJ |
Johnson & Johnson
|
3,629 | $921,657 | |
| 3 | ABBV |
AbbVie Inc.
|
2,605 | $655,522 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,978 | $382,673 | |
| 5 | PFE |
Pfizer Inc
This page
|
11,300 | $272,104 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,554 | $262,401 | |
| 7 | AMGN |
Amgen Inc
|
655 | $237,188 |
All Filings in PFE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $272,104 | 11,300 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $334,797 | 11,923 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $263,491 | 10,582 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $252,150 | 9,896 | Shares | Sole | 2025-11-05 | |
| No filing history on record for this holder in this stock. | ||||||